[ORGANIZATION]
QuantHealth
Featured in 4 tracked stories · first seen
Situations
GC Cell advances GCC2005 CAR-NK therapy development
4 clusters · 6 sources · last updated
Latest: GC Cell begins Phase 1b clinical trials for GCC2005
GC Cell is advancing its GCC2005 CAR-NK cell therapy, a CD5-targeted allogeneic treatment for refractory T-cell lymphoma. The company has partnered with QuantHealth to use AI-based clinical trial simulations to optimize
Also covered in
-
Shift Bioscience introduces new framework for AI virtual cell benchmarking
[TECHNOLOGY] · 5 sources ·